Lipoprotein-based drug delivery

Sara Busatto, Mayo Clinic in Jacksonville, Florida
Sierra A. Walker, Mayo Clinic in Jacksonville, Florida
Whisper Grayson, University of North Florida
Anthony Pham, Mayo Clinic in Jacksonville, Florida
Ming Tian, Mayo Clinic in Jacksonville, Florida
Nicole Nesto, University of North Florida
Jacqueline Barklund, University of North Florida
Joy Wolfram, Mayo Clinic in Jacksonville, Florida

Abstract

Lipoproteins (LPs) are circulating heterogeneous nanoparticles produced by the liver and intestines. LPs play a major role in the transport of dietary and endogenous lipids to target cells through cell membrane receptors or cell surface-bound lipoprotein lipase. The stability, biocompatibility, and selective transport of LPs make them promising delivery vehicles for various therapeutic and imaging agents. This review discusses isolation, manufacturing, and drug loading techniques used for LP-based drug delivery, as well as recent applications for diagnosis and treatment of cancer, atherosclerosis, and other life-threatening diseases.

 

Accessibility Statement

This item was created or digitized before April 24, 2027, or is a reproduction of legacy material created before that date. It is preserved in its original, unmodified state specifically for research, reference, or historical recordkeeping. In accordance with the ADA Title II Final Rule, the Library provides accessible versions of archival materials by request. If you are experiencing difficulty accessing the information on the site due to a disability, please submit a request through the following form for assistance.